<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Milbank Q</journal-id><journal-id journal-id-type="iso-abbrev">Milbank Q</journal-id><journal-id journal-id-type="pmc-domain-id">858</journal-id><journal-id journal-id-type="pmc-domain">milbank</journal-id><journal-id journal-id-type="publisher-id">MILQ</journal-id><journal-title-group><journal-title>The Milbank Quarterly</journal-title></journal-title-group><issn pub-type="ppub">0887-378X</issn><issn pub-type="epub">1468-0009</issn><publisher><publisher-name>Milbank Memorial Fund</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7077777</article-id><article-id pub-id-type="pmcid-ver">PMC7077777.1</article-id><article-id pub-id-type="pmcaid">7077777</article-id><article-id pub-id-type="pmcaiid">7077777</article-id><article-id pub-id-type="pmid">31800142</article-id><article-id pub-id-type="doi">10.1111/1468-0009.12436</article-id><article-id pub-id-type="publisher-id">MILQ12436</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Scholarship</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Scholarship</subject></subj-group></article-categories><title-group><article-title>The Association of State Opioid Misuse Prevention Policies With Patient&#8208; and Provider&#8208;Related Outcomes: A Scoping Review</article-title><alt-title alt-title-type="left-running-head">A.I. Mauri, T.N. Townsend, and R.L. Haffajee</alt-title><alt-title alt-title-type="right-running-head">State Opioid Misuse Prevention Policies</alt-title></title-group><contrib-group><contrib id="milq12436-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>MAURI</surname><given-names initials="AI">AMANDA I.</given-names></name><xref ref-type="aff" rid="milq12436-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="milq12436-aff-0002">
<sup>2</sup>
</xref><address><email>amauri@umich.edu</email></address></contrib><contrib id="milq12436-cr-0002" contrib-type="author"><name name-style="western"><surname>TOWNSEND</surname><given-names initials="TN">TARLISE N.</given-names></name><xref ref-type="aff" rid="milq12436-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="milq12436-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="milq12436-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="milq12436-cr-0003" contrib-type="author"><name name-style="western"><surname>HAFFAJEE</surname><given-names initials="RL">REBECCA L.</given-names></name><xref ref-type="aff" rid="milq12436-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="milq12436-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="milq12436-aff-0004">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="milq12436-aff-0001">
<label><sup>1</sup></label>
<institution>University of Michigan School of Public Health</institution>
</aff><aff id="milq12436-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Injury Prevention Center</named-content>
<institution>University of Michigan Medical School</institution>
</aff><aff id="milq12436-aff-0003">
<label><sup>3</sup></label>
<institution>University of Michigan Department of Sociology</institution>
</aff><aff id="milq12436-aff-0004">
<label><sup>4</sup></label>
<institution>RAND Corporation</institution>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><italic toggle="yes">Address correspondence to</italic>: Amanda I. Mauri, Department of Health Management and Policy, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI 48109 (email: <email>amauri@umich.edu</email>).</corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2020</year></pub-date><volume>98</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">354447</issue-id><issue-id pub-id-type="doi">10.1111/milq.v98.1</issue-id><fpage>57</fpage><lpage>105</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-31 19:26:05.010"><day>31</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2019 Milbank Memorial Fund</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="MILQ-98-57.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:MILQ-98-57.pdf"/><abstract><sec id="milq12436-sec-0010"><p>
<boxed-text position="anchor" content-type="box" orientation="portrait"><caption><title>Policy Points</title></caption><p>
<list list-type="bullet" id="milq12436-list-0001"><list-item><p>This scoping review reveals a growing literature on the effects of certain state opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state policies remain.</p></list-item><list-item><p>Policymakers interested in reducing the volume and dosage of opioids prescribed and dispensed can consider adopting robust prescription drug monitoring programs with mandatory access provisions and drug supply management policies, such as prior authorization policies for high&#8208;risk prescription opioids.</p></list-item><list-item><p>Further research should concentrate on potential unintended consequences of opioid misuse prevention policies, differential policy effects across populations, interventions that have not received sufficient evaluation (eg, Good Samaritan laws, naloxone access laws), and patient&#8208;related outcomes.</p></list-item></list>
</p></boxed-text>
</p></sec><sec id="milq12436-sec-0020"><title>Context</title><p>In the midst of an opioid crisis in the United States, an influx of state opioid misuse prevention policies has provided new opportunities to generate evidence of policy effectiveness that can inform policy decisions.&#160;We conducted a scoping review to synthesize the available evidence&#160;on the effectiveness of US state interventions to improve patient and provider outcomes related to opioid misuse and addiction.</p></sec><sec id="milq12436-sec-0030"><title>Methods</title><p>We searched six online databases to identify evaluations of state opioid policies. Eligible studies examined legislative and administrative policy interventions that evaluated (a) prescribing and dispensing, (b) patient behavior, or (c) patient health.</p></sec><sec id="milq12436-sec-0040"><title>Findings</title><p>Seventy&#8208;one articles met our inclusion criteria, including 41 studies published between 2016 and 2018. These articles evaluated nine types of state policies targeting opioid misuse. While prescription drug monitoring programs (PDMPs) have received considerable attention in the literature, far fewer studies addressed other types of state policy. Overall, evidence quality is very low for the majority of policies due to a small number of evaluations. Of interventions that have been the subject of considerable research, promising means of reducing the volume and dosages of opioids prescribed and dispensed include drug supply management policies and robust PDMPs. Due to low study number and quality, evidence is insufficient to draw conclusions regarding interventions targeting patient behavior and health outcomes, including naloxone access laws and Good Samaritan laws.</p></sec><sec id="milq12436-sec-0050"><title>Conclusions</title><p>Recent research has improved the evidence base on several state interventions targeting opioid misuse. Specifically, moderate evidence suggests that drug supply management policies and robust PDMPs reduce opioid prescribing. Despite the increase in rigorous evaluations, evidence remains limited for the majority of policies, particularly those targeting patient health&#8211;related outcomes.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="milq12436-kwd-0001">Opioid</kwd><kwd id="milq12436-kwd-0002">state policy</kwd><kwd id="milq12436-kwd-0003">scoping review</kwd><kwd id="milq12436-kwd-0004">drug overdose</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Centers for Disease Control and Prevention for the University of Michigan Injury Prevention Center</funding-source><award-id>#R49-CE-002099</award-id></award-group><award-group id="funding-0002"><funding-source>National Center for Advancing Translational Sciences of the National Institutes of Health</funding-source><award-id>#KL2TR002241</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="6"/><page-count count="49"/><word-count count="12886"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.8 mode:remove_FC converted:17.03.2020</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>